期刊
ORGANIC LETTERS
卷 24, 期 27, 页码 4971-4976出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.2c01974
关键词
-
资金
- National Institutes of Health (NIGMS) [R01GM110560]
- NIH [S10RR028859]
This study describes two strategies for enantioselective total synthesis of gelsenicine. One approach using chirality transfer cyclization fell short, while a separate asymmetric catalysis route utilizing bisphosphine-gold-catalyzed cyclization was pursued. A catalytic system was identified that provided a synthetic intermediate in high enantiopurity, allowing for the enantioselective formal total synthesis of (+)-gelsenicine.
ABSTRACT: Two strategies are described en route to an enantioselective total synthesis of gelsenicine. One approach centers on a chirality transfer cycloisomerization that ultimately fell short. Separately, an asymmetric catalysis route utilizing bisphosphine-gold-catalyzed cycloisomerization was pursued. A catalytic system was identified that provided a synthetic intermediate in our Gelsemium alkaloid syntheses in high enantiopurity and with absolute configuration determined by electronic circular dichroism, thus representing an enantioselective formal total synthesis of (+)-gelsenicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据